Cargando…
Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1‐p21/ZEB‐1 pathway
Our previous studies found overexpression of Musashi2 (MSI2) conduced to the progression and chemoresistance of pancreatic cancer (PC) by negative regulation of Numb and wild type p53 (wtp53). Now, we further investigated the novel signalling involved with MSI2 in PC. We identified inositol‐3‐phosph...
Autores principales: | Zhou, Lei, Sheng, WeiWei, Jia, Chao, Shi, Xiaoyang, Cao, Rongxian, Wang, Guosen, Lin, Yiheng, Zhu, Fang, Dong, Qi, Dong, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521282/ https://www.ncbi.nlm.nih.gov/pubmed/32779876 http://dx.doi.org/10.1111/jcmm.15676 |
Ejemplares similares
-
Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
por: Sheng, Weiwei, et al.
Publicado: (2020) -
Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
por: Sheng, Weiwei, et al.
Publicado: (2020) -
Down-regulation of MSMO1 promotes the development and progression of pancreatic cancer
por: Cao, Rongxian, et al.
Publicado: (2022) -
Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein
por: Sheng, Weiwei, et al.
Publicado: (2016) -
Correction: Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein
por: Sheng, Weiwei, et al.
Publicado: (2022)